Casdin Capital, LLC Q3 2018 Filing
Filed November 14, 2018
Portfolio Value
$822.8B
Holdings
36
Report Date
Q3 2018
Filing Type
13F-HR
All Holdings (36 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —LOXO ONCOLOGY INC | 360,000 | $61.5B | 7.47% | |
| 2 | 2L9BLUEPRINT MEDICINES CORP | 750,000 | $58.5B | 7.12% | |
| 3 | —MYOKARDIA INC | 805,000 | $52.5B | 6.38% | |
| 4 | AGIOAGIOS PHARMACEUTICALS INC | 579,776 | $44.7B | 5.43% | |
| 5 | SG7SAGE THERAPEUTICS INC | 312,000 | $44.1B | 5.36% | |
| 6 | BLFSBIOLIFE SOLUTIONS INC | 2,428,571 | $42.5B | 5.17% | |
| 7 | FATEFATE THERAPEUTICS INC | 2,550,000 | $41.5B | 5.05% | |
| 8 | NVTA1EURINVITAE CORP | 2,400,000 | $40.2B | 4.88% | |
| 9 | —BLUEBIRD BIO INC | 258,000 | $37.7B | 4.58% | |
| 10 | —SPARK THERAPEUTICS INC | 675,000 | $36.8B | 4.48% | |
| 11 | CDXSCODEXIS INC | 2,025,000 | $34.7B | 4.22% | |
| 12 | GBYSANGAMO THERAPEUTICS INC | 2,000,000 | $33.9B | 4.12% | |
| 13 | —MAGENTA THERAPEUTICS INC | 2,250,818 | $27.0B | 3.29% | |
| 14 | ILMNILLUMINA INC | 71,500 | $26.2B | 3.19% | |
| 15 | —GENMARK DIAGNOSTICS INC | 3,500,000 | $25.7B | 3.13% | |
| 16 | —AUDENTES THERAPEUTICS INC | 625,000 | $24.7B | 3.01% | |
| 17 | ALNYALNYLAM PHARMACEUTICALS INC | 270,000 | $23.6B | 2.87% | |
| 18 | VYGRVOYAGER THERAPEUTICS INC | 1,135,000 | $21.5B | 2.61% | |
| 19 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 440,000 | $16.7B | 2.03% | |
| 20 | EVHEVOLENT HEALTH INC | 550,000 | $15.6B | 1.90% | |
| 21 | EDITEDITAS MEDICINE INC | 460,000 | $14.6B | 1.78% | |
| 22 | ONCBEIGENE LTD | 70,000 | $12.1B | 1.47% | |
| 23 | 2JQGRITSTONE ONCOLOGY INC | 720,586 | $10.3B | 1.25% | |
| 24 | CRSPCRISPR THERAPEUTICS AG | 220,000 | $9.8B | 1.19% | |
| 25 | —CONSTELLATION PHARMCETICLS I | 1,314,743 | $8.8B | 1.08% | |
| 26 | EP3ORASURE TECHNOLOGIES INC | 525,000 | $8.1B | 0.99% | |
| 27 | FIXXEURHOMOLOGY MEDICINES INC | 350,000 | $8.0B | 0.97% | |
| 28 | CLVSEURCLOVIS ONCOLOGY INC | 235,000 | $6.9B | 0.84% | |
| 29 | SRPTSAREPTA THERAPEUTICS INC | 40,000 | $6.5B | 0.79% | |
| 30 | CDNACAREDX INC | 200,000 | $5.8B | 0.70% | |
| 31 | NEOGNEOGEN CORP | 65,000 | $4.6B | 0.57% | |
| 32 | CELGCELGENE CORP | 50,000 | $4.5B | 0.54% | Call |
| 33 | GILDGILEAD SCIENCES INC | 50,000 | $3.9B | 0.47% | Call |
| 34 | CTMXCYTOMX THERAPEUTICS INC | 207,500 | $3.8B | 0.47% | |
| 35 | —NEON THERAPEUTICS INC | 338,345 | $2.9B | 0.35% | |
| 36 | JNCEEURJOUNCE THERAPEUTICS INC | 375,000 | $2.4B | 0.30% |